Anthem Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 |
|---|---|
| Revenue | 565.74 |
| Operating Expense | 342.58 |
| Net Profit | 148.34 |
| Net Profit Margin | 26.22 |
| Earning Per Share | 2.65 |
| EBIDTA | 222.63 |
| Effective Tax Rate | 22.44 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 565.74 |
| Operating Expense | 342.58 |
| Net Profit | 148.34 |
| Net Profit Margin | 26.22 |
| Earning Per Share | 2.65 |
| EBIDTA | 222.63 |
| Effective Tax Rate | 22.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,840.65 | 1,417.54 | 1,056.92 |
| Operating Expenses Annual | 1,151.64 | 912.65 | 627.87 |
| Operating Profit Annual | 798.45 | 575.41 | 568.23 |
| Interest Annual | 9.09 | 9.14 | 6.75 |
| Depreciation | 77.94 | 81.49 | 63.70 |
| Net Profit Annual | 506.19 | 374.78 | 385.67 |
| Tax Annual | 205.24 | 109.99 | 112.11 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,840.65 |
| Operating Expenses Annual | 1,151.64 |
| Operating Profit Annual | 798.45 |
| Interest Annual | 9.09 |
| Depreciation | 77.94 |
| Net Profit Annual | 506.19 |
| Tax Annual | 205.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 183.85 | 342.79 | 348.87 |
| Cash Flow from Operations | 439.84 | 164.41 | 318.98 |
| Cash Flow from Investing | -246.31 | -191.76 | -377.91 |
| Cash Flow from Financing | -66.42 | -131.59 | 52.85 |
| Cash Flow at the End | 310.95 | 183.85 | 342.79 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 183.85 |
| Cash Flow from Operations | 439.84 |
| Cash Flow from Investing | -246.31 |
| Cash Flow from Financing | -66.42 |
| Cash Flow at the End | 310.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 43.39 | 40.60 | 48.86 |
| PBIT Margin (%) | 39.16 | 34.85 | 42.83 |
| PBT Margin (%) | 34.95 | 31.09 | 37.91 |
| Net PROFIT Margin (%) | 27.50 | 26.44 | 36.49 |
| Return On Networth / Equity (%) | 22.98 | 20.40 | 22.27 |
| Return On Networth /Employed (%) | 30.46 | 24.74 | 27.47 |
| Return On Assets (%) | 21.45 | 18.77 | 23.35 |
| Total Debt / Equity (X) | 0.06 | 0.08 | 0.05 |
| Asset Turnover Ratio (%) | 0.78 | 0.71 | 0.64 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 43.39 |
| PBIT Margin (%) | 39.16 |
| PBT Margin (%) | 34.95 |
| Net PROFIT Margin (%) | 27.50 |
| Return On Networth / Equity (%) | 22.98 |
| Return On Networth /Employed (%) | 30.46 |
| Return On Assets (%) | 21.45 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 0.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 624.06 | 477.69 | 448.89 |
| Total Current Assets Annual | 1,664.07 | 1,445.49 | 1,319.62 |
| Non Current Assets Annual | 1,171.49 | 878.74 | 673.39 |
| Total Shareholders Funds Annual | 2,473.21 | 1,933.07 | 1,741.62 |
| Total Assets Annual | 2,835.56 | 2,324.23 | 1,993.02 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 624.06 |
| Total Current Assets Annual | 1,664.07 |
| Non Current Assets Annual | 1,171.49 |
| Total Shareholders Funds Annual | 2,473.21 |
| Total Assets Annual | 2,835.56 |
EPS (INR)
Expected
2.42
Reported
2.43
Surprise
0.41%
Mar 2025
EPS beaten by 0.41%
Jun 2024
EPS beaten by 0.00%
